Retraction
Artesunate Suppresses the Growth of Lung Cancer Cells by Downregulating the AKT/Survivin Signaling Pathway
Paper Information
Record ID:
57916
Author(s):
Journal:
Publication Date:
March 25, 2022
Retraction Date:
December 29, 2023
(1.9 year years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (10)
10
Total Citations3
Post-Retraction(30.0%)
6
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
2
Within 30 days
3
Within 1 year
0
After 2+ years
301
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Anti-tumor mechanism of artesunate
Xiaoyu Fan, Yiming Yan, Yafei Li et al. (5 authors)
Frontiers in Pharmacology
Open Access
Published: Oct 2024
1 citation
1 citation
301 days after retraction
Exploring the mechanism of action of artesunate against non-small cell lung cancer based on network pharmacology and molecular docking
Qi Liu, Shen Faqian, Hu Ma
Frontiers in Medical Science Research
Open Access
Published: Jan 2024
1 citation
1 citation
3 days after retraction
Pretreatment of artesunate promoted hepatocyte proliferation by activating the PI3K/Akt/mTOR signaling pathway in mice
LU Chang-you, Xinkai Li, Chao Fang et al. (6 authors)
Acta Cirúrgica Brasileira
Open Access
Published: Jan 2024
1 citation
1 citation
3 days after retraction
Applicability of Redirecting Artemisinins for New Targets
Jacob Golenser, Nicholas H. Hunt, Ida Birman et al. (7 authors)
Global Challenges
Open Access
Published: Oct 2023
3 citations
3 citations
63 days before retraction
Artesunate, as an Hsp90 inhibitor, inhibits the proliferation of Burkitt’s lymphoma cells by inhibiting AKT and ERK
Li Yuan-Ce, Qi Zhang, Zhang Hong-Yang et al. (7 authors)
Frontiers in Pharmacology
Open Access
Published: Aug 2023
4 citations
4 citations
120 days before retraction
Dihydromyricetin suppresses tumor growth via downregulation of the EGFR/Akt/survivin signaling pathway
Xiaoying Li, Li Zhou, Ruike Wang et al. (5 authors)
Journal of Biochemical and Molecular Toxicology
Published: Feb 2023
7 citations
7 citations
313 days before retraction
Retracted: Artesunate Suppresses the Growth of Lung Cancer Cells by Downregulating the AKT/Survivin Signaling Pathway
BioMed Research International
BioMed Research International
Open Access
Published: Jan 2023
362 days before retraction
Artesunate Alleviates Hyperoxia-Induced Lung Injury in Neonatal Mice by Inhibiting NLRP3 Inflammasome Activation
Bin Xie, Shouye Li, Wuxia Bai et al. (5 authors)
Evidence-based Complementary and Alternative Medicine
Open Access
Published: Jan 2023
6 citations
6 citations
362 days before retraction
Lessons learned from the discovery and development of the sesquiterpene lactones in cancer therapy and prevention
Israa Ahmad Cheikh, Chirine El‐Baba, Ali Youssef et al. (6 authors)
Expert Opinion on Drug Discovery
Published: Nov 2022
17 citations
17 citations
410 days before retraction
Quick Stats
Total Citations:
10
Years Since Retraction:
1.9 year
Open Access:
Yes
Last Checked:
Jul 24, 2025